Robin Geever

1 presentation

W39. PSYCHOPHARMACOLOGY OF ENX-104: A POTENT DOPAMINE (DA) D2/D3 RECEPTOR ANTAGONIST FOR THE TREATMENT OF NEUROPSYCHIATRIC DISORDERS ASSOCIATED WITH ANHEDONIA

2026 ASCP Annual Meeting